Multiple studies have attempted to combine other tumour markers such as Human epididymis protein 4 (HE4) with CA125 to reduce false-positive diagnostic tests in the presence of benign and inflammatory lesions in younger women [34,35,36]. The gene discussed is WFDC2; the disease is neoplasm.